Canal Insurance Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-40,000
Closed -$5.16M 72
2017
Q2
$5.16M Hold
40,000
1.89% 17
2017
Q1
$4.37M Hold
40,000
1.51% 24
2016
Q4
$2.95M Buy
40,000
+20,000
+100% +$1.47M 1.04% 33
2016
Q3
$1.74M Hold
20,000
0.55% 50
2016
Q2
$1.72M Hold
20,000
0.57% 49
2016
Q1
$1.59M Buy
+20,000
New +$1.59M 0.56% 51
2015
Q2
Sell
-21,992
Closed -$2.59M 82
2015
Q1
$2.59M Buy
21,992
+2,396
+12% +$283K 0.87% 40
2014
Q4
$2.33M Sell
19,596
-10,696
-35% -$1.27M 0.78% 42
2014
Q3
$3.4M Sell
30,292
-1,100
-4% -$124K 1.08% 32
2014
Q2
$2.97M Buy
31,392
+10,696
+52% +$1.01M 0.9% 38
2014
Q1
$854K Sell
20,696
-696
-3% -$28.7K 0.28% 69
2013
Q4
$1.59M Buy
21,392
+696
+3% +$51.7K 0.53% 58
2013
Q3
$814K Buy
20,696
+10,000
+93% +$393K 0.27% 70
2013
Q2
$854K Buy
+10,696
New +$854K 0.3% 70